NCT06074536 Impact of Training Patient-centered Approach on Shared Decision in Colorectal Cancer Screening
| NCT ID | NCT06074536 |
| Status | Recruiting |
| Phase | — |
| Sponsor | CNGE Conseil |
| Condition | Colorectal Cancer Screening |
| Study Type | INTERVENTIONAL |
| Enrollment | 400 participants |
| Start Date | 2024-03-06 |
| Primary Completion | 2027-05-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 400 participants in total. It began in 2024-03-06 with a primary completion date of 2027-05-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to compare the effect of face-to-face training of general practitioners on the implementation of a shared decision (in the context of colorectal cancer screening), versus current practice (i.e. without training in the patient-centered approach).
Eligibility Criteria
Inclusion Criteria: * Patient aged 50 to 74: * Eligible for organized CRC screening, * Having declared as attending clinician a general practitioner investigator of the study ✓ Consulting their attending clinician for the duration of the study, * AND able and willing to comply with all trial requirements Non inclusion Criteria: \- ✓ Screened for CRC less than 2 years ago * Not eligible for organized CRC screening: * History of adenomas or CRC: \- Family (1st degree) * Personal history of IBD: * Crohn's disease * Ulcerative colitis) * Hereditary predispositions: * Familial adenomatous polyposis * Hereditary non-polyposis colorectal cancer (Lynch syndrome) * Patient with symptoms requiring colonoscopy * Having a level of literacy that does not allow the completion of the self-questionnaire. * Having an inability to give express consent. * Being under guardianship, curatorship or having cognitive disorders
Contact & Investigator
Isabelle AUGER-AUBIN, Pr
STUDY CHAIR
cabinet de groupe pluriprofessionnel 40 rue Carnot 95230 Soisy-Sous-Montmorency
Frequently Asked Questions
Who can join the NCT06074536 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 74 Years, studying Colorectal Cancer Screening. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06074536 currently recruiting?
Yes, NCT06074536 is actively recruiting participants. Contact the research team at isabelle.auger-aubin@u-paris.fr for enrollment information.
Where is the NCT06074536 trial being conducted?
This trial is being conducted at Soisy-sous-Montmorency, France.
Who is sponsoring the NCT06074536 clinical trial?
NCT06074536 is sponsored by CNGE Conseil. The principal investigator is Isabelle AUGER-AUBIN, Pr at cabinet de groupe pluriprofessionnel 40 rue Carnot 95230 Soisy-Sous-Montmorency. The trial plans to enroll 400 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.